Advertisement

Tic Emergencies

  • Vanessa K. Hinson
  • Christopher G. Goetz
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Patient 1: The parents of a 16-year-old boy ask that their son be urgently evaluated for an exacerbation of his tics. He was diagnosed with Gilles de la Tourette’s syndrome (GTS) at age 5 years and never required pharmacotherapy for his tics. Since the start of the school year and the transition to junior high school, he has developed frequent grunting, coughing, and shouting. These vocal tics are extremely disruptive and socially embarrassing. Classmates have commented, some heckling him, and one concerned student asked him if he was taking illicit drugs. The boy refuses to go to school and his grades are dropping. He recently had a bad cold, and started taking pseudonephrine, and feels his tics are even worse. On examination, there are mild multifocal motor tics, and severe repetitive vocal tics. The remainder of the examination is normal.

Keywords

Attention Deficit Hyperactivity Disorder Botulinum Toxin Choreic Movement Pediatric Autoimmune Neuropsychiatric Disorder Associate With Streptococcal Tardive Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette’s syndrome: the first two decades. Pediatrics 1998;102:14–19.PubMedCrossRefGoogle Scholar
  2. 2.
    Goetz CG, Tanner CM, Stebbins GT, et al. Adult tics in Gilles de la Tourette’s syndrome: description and risk factors. Neurology 1992;42:784–788.PubMedGoogle Scholar
  3. 3.
    Kompoliti K, Goetz CG, Leurgans S, et al. Estrogen, Progesterone, and tic severity in woman with Gilles de la Tourette syndrome. Neurology 2001;57(8):1519.PubMedGoogle Scholar
  4. 4.
    Erenberg G, Cruse RP, Rothner AD. Gilles de la Tourette’s syndrome: effect of stimulant drugs. Neurology 1985;35:1346–1348.PubMedGoogle Scholar
  5. 5.
    Price RA, Leckman JF, Pauls DL, et al. Gilles de la Tourette syndrome: tics and central nervous system stimulants in twins and non-twins. Neurology 1986;36:232–237.PubMedGoogle Scholar
  6. 6.
    Shafii M. The effects of sympathomimetic and antihistaminic agents on chronic motor tics and Tourette’s disorder. N Engl J Med 1986;315:1228–1229.PubMedCrossRefGoogle Scholar
  7. 7.
    Burd L, Kerbeshian J Fisher W, Gascon G. Anticonvulsant medications: an iatrogenic cause of tic disorders. Can J Psychiatry 1986;31:419–423.PubMedGoogle Scholar
  8. 8.
    Fras I. Gilles de la Tourette’s syndrome: effects of tricyclic antidepressants. NY State J Med 1978;78:1230–1232.Google Scholar
  9. 9.
    Gatto E, Pikielny R, Micheli F. Fluoxetine in Tourette’s syndrome. Am J Psychiatry 1994;151:946–947.PubMedGoogle Scholar
  10. 10.
    Mesulam M. Cocaine and Tourette’s syndrome. N Engl J Med 1986;315:389.Google Scholar
  11. 11.
    Sallee FR, Nesbitt L, Jackson C, et al. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder. Am J Psychiatry 1997;154:1057–1062.PubMedGoogle Scholar
  12. 12.
    Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48:358–362.PubMedGoogle Scholar
  13. 13.
    Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord 1994;9:347–349.PubMedCrossRefGoogle Scholar
  14. 14.
    Marras C, Andrews, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001;56(5):605–610.PubMedGoogle Scholar
  15. 15.
    Scott BL, Jankovic J, Donovan DT. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette’s syndrome. Mov Disord 1996;11:431–433.PubMedCrossRefGoogle Scholar
  16. 16.
    Salloway S, Stewart CF, Israeli L, et al. Botulinum toxin for refractory vocal tics. Mov Disord 1996;11:746–748.PubMedCrossRefGoogle Scholar
  17. 17.
    Goetz CG, Klawans HL. Gilles de la Tourette syndrome and compressive neuropathies. Ann Neurol 1980;8:453.PubMedCrossRefGoogle Scholar
  18. 18.
    Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette’s syndrome. Mov Disord 1996;11(5):563–566.PubMedCrossRefGoogle Scholar
  19. 19.
    Riley DE, Lang AE. Pain in Gilles de la Tourette syndrome and related tic disorders. Le Journal Canadien Des Sciences Neurologiques 1989;16:439–441.Google Scholar
  20. 20.
    Kumar R, Lang AE. Secondary Tic Disorders. Neurol Clin 1997;15(2):309–331.PubMedCrossRefGoogle Scholar
  21. 21.
    von Economo C. Encephalitis Lethargica: Its Sequelae and Treatment. Oxford University Press, London: 1931.Google Scholar
  22. 22.
    Turley JM. Tourette-like disorder after herpes simplex encephalitis. Am J Psychiatry 1988;145:1604–1605.PubMedGoogle Scholar
  23. 23.
    Northam RS, Singer HS. Postencephalitic Tourette-like syndrome in a child. Neurology 1991;4:592–593.Google Scholar
  24. 24.
    McDaniel JS, Summerville. Tic disorder associated with encephalopathy in advanced HIV disease. Gen Hosp Psychiat 1974;125:593–594.Google Scholar
  25. 25.
    Behan P, Geschwind N, Quadfase FA. Coprolalia in Sydenham’s chorea. Abstract. First International Gilles de la Tourette Syndrome Meeting, New York: 1981.Google Scholar
  26. 26.
    Lees AJ. Tics occurring in association with neurological disorders. In: Tics and Related Disorders. Churchill Livingstone, New York: 1985:70–82.Google Scholar
  27. 27.
    Swedo SE. Sydenham’s chorea: a model for childhood autoimmune psychiatric disorders. JAMA 1994;272:1788–1791.PubMedCrossRefGoogle Scholar
  28. 28.
    Pulst S, Walshe TM, Romero JA. Carbon Monoxide Poisoning with Features of Gilles de la Tourette’s Syndrome. Arch Neurol 1983;40:443–444.PubMedGoogle Scholar
  29. 29.
    Sacks OW. Tourettism in strokes. Tourette Syndrome Association Newsletter 1980 (VII:4:7).Google Scholar
  30. 30.
    Jankovic J. Tics in other neurologic disorders. In: Kurlan R, ed. Handbook of Tourette’s syndrome and related tic and behavioral disorders. Marcell Dekker, New York: 1993:167–182.Google Scholar
  31. 31.
    Krauss JK, Jankovic J. Tics secondary to craniocerebral trauma. Mov Disord 1997;12(5):776–782.PubMedCrossRefGoogle Scholar
  32. 32.
    Kompoliti K, Goetz CG. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord 1998;13(3):477–480.PubMedCrossRefGoogle Scholar
  33. 33.
    Bruun RD. Subtle and under-recognized side effects of neuroleptic treatment in children with Tourette’s disorder. Am J Psychiatry 1988;145:621–624.PubMedGoogle Scholar
  34. 34.
    Shapiro E, Shapiro AK. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients. In: Friedhoff AJ, Chase TN, eds. Gilles de la Tourette Syndrome. Adv Neurol, Vol. 35. Raven, New York: 1982; 413.Google Scholar
  35. 35.
    Lang A. Patient perception of tics and other movement disorders. Neurology 1991;41:223–228.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Vanessa K. Hinson
    • 1
  • Christopher G. Goetz
    • 2
  1. 1.Department of NeurosciencesMedical University of South CarolinaCharleston
  2. 2.Department of Neurological SciencesRush University Medical CenterChicago

Personalised recommendations